Published 24 hours ago

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer - Pharming (NASDAQ:PHAR)

Summary by Benzinga

Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces today that the Board of Directors has nominated Fabrice Chouraqui to become Pharming's new Executive Director and Chief Executive Officer, succeeding Sijmen de Vries. Pharming will nominate Mr. Chouraqui for the appointment as Executive Director and Chief Executive Officer for a term of four years at an upcoming Extraordinary Gene…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources0

Leaning Left1Leaning Right1Center1Last Updated5 hours agoBias Distribution

33% Left, 33% Center, 33% Right

Bias Distribution

33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right

34% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer - Pharming (NASDAQ:PHAR)

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics